ALKBH5 and acute myeloid leukemia: In conclusion, our findings indicate that ALKBH5 is overexpressed in AML and contributes to ADR resistance by inhibiting m6A modification, thereby promoting TUG1 expression in a YTHDF2-dependent manner.